- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03093311
Near Infrared Spectroscopy for Detection of Cerebral Desaturation After Positioning for Neurosurgical Procedures
September 28, 2019 updated by: Dostalova Vlasta, MD, PhD, University Hospital Hradec Kralove
Near Infrared Spectroscopy for Detection of Cerebral Desaturation After Positioning for Neurosurgical Procedure
The occurrence of postoperative cognitive dysfunction (POCD) might be related to intraoperative cerebral desaturation.
Positioning for neurosurgical procedures are associated with head rotation, elevation, flexion or extention that may affect blood brain inflow and outflow.
Anatomical variations of Willis circle could affect the cerebral blood flow in extreme head position with the development of cerebral ischemia or functional changes of brain.
Investigators suppose that detection of cerebral tissue desaturation and its prompt correction could modify the occurence of POCD after these procedures.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Standardized anesthesia and perioperative care will be provided to all patiens with positioning for neurosurgical or spinal procedures, where the head is elevated, extended.
flected or rotated.
In group A before the start of general anesthesia, the baseline level of cerebral tissue oxygenation (rScO2) will be measured using the near-infrared spectroscopy NIRS (Invivo Medtronic) .
Continuous measurement of rScO2 will be used for detection of cerebral tissue desaturation.
Each desaturation episode will be managed according to a standardized protocol - correction of extreme head position will be followed by optimalisation of mean arterial pressure (MAP), arterial hemoglobin oxygen saturation, end tidal carbon dioxide concentration and a level of hemoglobine concentration.
In group B neither measurement of rScO2 nor interventions are provided.
Cognitive dysfunction will be assessed by Adenbrooke test before operation and on the fifth postoperative day.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hradec Kralove, Czechia, 50005
- University Hospital Hradec Kralove
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Glasgow Coma Scale 15, American Society of Anaesthesiologists (ASA) Physical Status Classification System Grade I-III, patient positioning with elevation, rotation, flexion or extention of head
Exclusion Criteria:
- Inability to past the Addenbrooke test, postoperative ventilation, awake phase during surgery, lung disease with retention of carbon dioxide, neurological disease before surgery (aphasia, paresis, blindness, deafness)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Arm A
Brain tissue oxygenation is measured by NIRS.
In time of desaturation the interventions according to NIRS based protocol start.
|
Each desaturation episode will be managed according to a standardized protocol - correction of extreme head position will be followed by optimisation of mean arterial pressure (MAP), arterial hemoglobin oxygen saturation, end tidal carbon dioxide concentration and a level of hemoglobine concentration.
|
NO_INTERVENTION: Arm B
Brain tissue oxygenation is not measured.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of incidence of postoperative cognitive dysfunction (POCD)
Time Frame: 1 day before operation and the fifth´day
|
Addenbrooke test
|
1 day before operation and the fifth´day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operative position of patient
Time Frame: first 30 minutes
|
In grades from neutral position
|
first 30 minutes
|
Age of patients
Time Frame: the first 5 minutes
|
18 to 79
|
the first 5 minutes
|
Level of exhaled carbon dioxide
Time Frame: every 5 minutes
|
In torr
|
every 5 minutes
|
Type and duration of procedure
Time Frame: 10 minutes after procedure
|
In minutes
|
10 minutes after procedure
|
Dose of catecholamines
Time Frame: 5 minutes after procedure
|
In microgramms per kg per minute
|
5 minutes after procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2017
Primary Completion (ACTUAL)
December 31, 2018
Study Completion (ACTUAL)
June 30, 2019
Study Registration Dates
First Submitted
March 14, 2017
First Submitted That Met QC Criteria
March 21, 2017
First Posted (ACTUAL)
March 28, 2017
Study Record Updates
Last Update Posted (ACTUAL)
October 1, 2019
Last Update Submitted That Met QC Criteria
September 28, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UHHradecKralove 2017/01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Dysfunction
-
Loma Linda UniversityCompleted1. Postoperative Cognitive DysfunctionUnited States
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingPOCD - Postoperative Cognitive DysfunctionChina
-
Mu Dong LiangNot yet recruitingPostoperative Cognitive Dysfunction(POCD)
-
HealthPartners InstituteCompletedPost Operative Cognitive DysfunctionUnited States
-
Burcu Ozalp HorsanaliCompletedPost Operative Cognitive Dysfunction
-
ImmunoChem Therapeutics, LLCNational Cancer Institute (NCI); Northwestern MedicineRecruitingCognitive Dysfunction, Cognitive DisorderUnited States
-
Attikon HospitalCompleted
-
Xijing HospitalFirst Affiliated Hospital Xi'an Jiaotong University; Shanghai 10th People's... and other collaboratorsTerminatedPost Operative Cognitive DysfunctionChina
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedPost Operative Cognitive DysfunctionUnited States
-
Mayo ClinicCompletedCognitive Impairment | Mild Cognitive Impairment | Neurocognitive DysfunctionUnited States
Clinical Trials on NIRS based protocol
-
University Hospital TuebingenUnknownAttention-deficit Hyperactivity Disorder of Childhood or Adolescence NosGermany
-
Universitat Jaume IMinisterio de Economía y Competitividad, SpainUnknown
-
Columbia UniversityRecruitingPreeclampsia | Maternal HypertensionUnited States
-
Mohammed RamadanNot yet recruitingSingle Tooth Lost | Partially Edentulous MaxillaEgypt
-
Tel-Aviv Sourasky Medical CenterUnknownLiver Cirrhosis | Coagulopathy
-
Hospital Israelita Albert EinsteinTerminated
-
Universitat Jaume INot yet recruiting
-
Tulane UniversityXiamen UniversityActive, not recruitingHypertension | Cardiovascular Disease | Diabetes | DyslipidemiaUnited States, China
-
Lawson Health Research InstituteCompletedRespiration, ArtificialCanada
-
Dhritiman ChakrabartiCompletedCerebral Venous ThrombosisIndia